€22 Million Investment for Utrecht-Based Innovation in Heart Surgery
Could bypass surgery one day be performed without sawing open the breastbone? The Utrecht-based company AMT Medical is bringing that vision closer to reality. With a new €22 million investment, the company is accelerating the development and commercialization of its innovative technology — which uses a laser and a small clip instead of traditional sutures.
This method could enable minimally invasive heart bypass procedures through a small keyhole-sized incision between the ribs, potentially leading to significantly faster recovery times for patients.
We’re proud to have invested in AMT Medical back in 2017, supporting their mission from the early days. The recent funding round includes backing from healthcare entrepreneur Johan Bender, Invest-NL, Oost NL and the European Innovation Council next to current shareholders. The company is now preparing for CE certification in Europe and clinical trials in the U.S., potentially in partnership with the Mayo Clinic.
Interested to learn more? Read the full article here.
